These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16557573)

  • 1. Sex differences in risk of lung cancer: Expression of genes in the PAH bioactivation pathway in relation to smoking and bulky DNA adducts.
    Mollerup S; Berge G; Baera R; Skaug V; Hewer A; Phillips DH; Stangeland L; Haugen A
    Int J Cancer; 2006 Aug; 119(4):741-4. PubMed ID: 16557573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in susceptibility to PAHs is an intrinsic property of human lung adenocarcinoma cells.
    Uppstad H; Osnes GH; Cole KJ; Phillips DH; Haugen A; Mollerup S
    Lung Cancer; 2011 Mar; 71(3):264-70. PubMed ID: 20951464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients.
    Mollerup S; Ryberg D; Hewer A; Phillips DH; Haugen A
    Cancer Res; 1999 Jul; 59(14):3317-20. PubMed ID: 10416585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of estrogen receptor in regulation of polycyclic aromatic hydrocarbon metabolic activation in lung.
    Berge G; Mollerup S; ØVrebø S; Hewer A; Phillips DH; Eilertsen E; Haugen A
    Lung Cancer; 2004 Sep; 45(3):289-97. PubMed ID: 15301869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CYP1A1, CYP1B1 and CYP3A, and polycyclic aromatic hydrocarbon-DNA adduct formation in bronchoalveolar macrophages of smokers and non-smokers.
    Piipari R; Savela K; Nurminen T; Hukkanen J; Raunio H; Hakkola J; Mäntylä T; Beaune P; Edwards RJ; Boobis AR; Anttila S
    Int J Cancer; 2000 Jun; 86(5):610-6. PubMed ID: 10797280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between smoking, polymorphisms in polycyclic aromatic hydrocarbon (PAH) metabolism and conjugation genes and PAH-DNA adducts in prostate tumors differ by race.
    Nock NL; Tang D; Rundle A; Neslund-Dudas C; Savera AT; Bock CH; Monaghan KG; Koprowski A; Mitrache N; Yang JJ; Rybicki BA
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1236-45. PubMed ID: 17548691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of CYP1B1 and CYP1A1 expression in human mammary epithelial cells: role of the aryl hydrocarbon receptor in polycyclic aromatic hydrocarbon metabolism.
    Larsen MC; Angus WG; Brake PB; Eltom SE; Sukow KA; Jefcoate CR
    Cancer Res; 1998 Jun; 58(11):2366-74. PubMed ID: 9622076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking-associated bulky DNA adducts in bronchial tissue related to CYP1A1 MspI and GSTM1 genotypes in lung patients.
    Schoket B; Phillips DH; Kostic S; Vincze I
    Carcinogenesis; 1998 May; 19(5):841-6. PubMed ID: 9635872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cytochrome p4501 family members in the metabolic activation of polycyclic aromatic hydrocarbons in mouse epidermis.
    Kleiner HE; Vulimiri SV; Hatten WB; Reed MJ; Nebert DW; Jefcoate CR; DiGiovanni J
    Chem Res Toxicol; 2004 Dec; 17(12):1667-74. PubMed ID: 15606143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of polymorphisms in genes involved in polycyclic aromatic hydrocarbon metabolism with urinary phenanthrene metabolite ratios in smokers.
    Hecht SS; Carmella SG; Yoder A; Chen M; Li ZZ; Le C; Dayton R; Jensen J; Hatsukami DK
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1805-11. PubMed ID: 17035385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative RT-PCR measurement of cytochromes p450 1A1, 1B1, and 2B7, microsomal epoxide hydrolase, and NADPH oxidoreductase expression in lung cells of smokers and nonsmokers.
    Willey JC; Coy EL; Frampton MW; Torres A; Apostolakos MJ; Hoehn G; Schuermann WH; Thilly WG; Olson DE; Hammersley JR; Crespi CL; Utell MJ
    Am J Respir Cell Mol Biol; 1997 Jul; 17(1):114-24. PubMed ID: 9224217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human lung microsomal cytochrome P4501A1 (CYP1A1) activities: impact of smoking status and CYP1A1, aryl hydrocarbon receptor, and glutathione S-transferase M1 genetic polymorphisms.
    Smith GB; Harper PA; Wong JM; Lam MS; Reid KR; Petsikas D; Massey TE
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):839-53. PubMed ID: 11489750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycyclic aromatic hydrocarbon-inducible DNA adducts: evidence by 32P-postlabeling and use of knockout mice for Ah receptor-independent mechanisms of metabolic activation in vivo.
    Kondraganti SR; Fernandez-Salguero P; Gonzalez FJ; Ramos KS; Jiang W; Moorthy B
    Int J Cancer; 2003 Jan; 103(1):5-11. PubMed ID: 12455047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity.
    Alexandrov K; Rojas M; Geneste O; Castegnaro M; Camus AM; Petruzzelli S; Giuntini C; Bartsch H
    Cancer Res; 1992 Nov; 52(22):6248-53. PubMed ID: 1423269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue specific induction of cytochrome P450 (CYP) 1A1 and 1B1 in rat liver and lung following in vitro (tissue slice) and in vivo exposure to benzo(a)pyrene.
    Harrigan JA; McGarrigle BP; Sutter TR; Olson JR
    Toxicol In Vitro; 2006 Jun; 20(4):426-38. PubMed ID: 16198082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of Cyp1a1 and Cyp1b1 and formation of DNA adducts in C57BL/6, Balb/c, and F1 mice following in utero exposure to 3-methylcholanthrene.
    Xu M; Nelson GB; Moore JE; McCoy TP; Dai J; Manderville RA; Ross JA; Miller MS
    Toxicol Appl Pharmacol; 2005 Nov; 209(1):28-38. PubMed ID: 15885734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of CYP1A1 and CYP1B1 and formation of carcinogen-DNA adducts in normal human mammary epithelial cells treated with benzo[a]pyrene.
    Keshava C; Divi RL; Whipkey DL; Frye BL; McCanlies E; Kuo M; Poirier MC; Weston A
    Cancer Lett; 2005 Apr; 221(2):213-24. PubMed ID: 15808407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of DNA adducts in smokers' lung and urothelium by 32P-postlabelling: metabolic phenotype dependence and comparisons with other exposure markers.
    Bartsch H; Castegnaro M; Camus AM; Schouft A; Geneste O; Rojas M; Alexandrov K
    IARC Sci Publ; 1993; (124):331-40. PubMed ID: 8225503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking lung cancer patients: correlations between tissues and detection by 32P-postlabelling and immunoassay.
    Gyorffy E; Anna L; Gyori Z; Segesdi J; Minárovits J; Soltész I; Kostic S; Csekeo A; Poirier MC; Schoket B
    Carcinogenesis; 2004 Jul; 25(7):1201-9. PubMed ID: 15001535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cytochromes P450 1A1 and 1B1 in human lung from smokers, non-smokers, and ex-smokers.
    Kim JH; Sherman ME; Curriero FC; Guengerich FP; Strickland PT; Sutter TR
    Toxicol Appl Pharmacol; 2004 Sep; 199(3):210-9. PubMed ID: 15364538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.